Clinical Trial Update: Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating curcumin for reduction of mucositis in autologous transplant patients is in progress with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Tata Memorial Centre | Conditions: Oral Mucositis (Ulcerative) | Phase 3 | Status: UNKNOWN